Cargando…

Effect of Different Adjuvants on the Longevity and Strength of Humoral and Cellular Immune Responses to the HCV Envelope Glycoproteins

Infection by Hepatitis C virus (HCV) can lead to liver cirrhosis/hepatocellular carcinoma and remains a major cause of serious disease morbidity and mortality worldwide. However, current treatment regimens remain inaccessible to most patients, particularly in developing countries, and, therefore, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akache, Bassel, Deschatelets, Lise, Harrison, Blair A., Dudani, Renu, Stark, Felicity C., Jia, Yimei, Landi, Amir, Law, John L. M., Logan, Michael, Hockman, Darren, Kundu, Juthika, Tyrrell, D. Lorne, Krishnan, Lakshmi, Houghton, Michael, McCluskie, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963754/ https://www.ncbi.nlm.nih.gov/pubmed/31816920 http://dx.doi.org/10.3390/vaccines7040204

Ejemplares similares

Sulfated archaeol glycolipids: Comparison with other immunological adjuvants in mice
por: Akache, Bassel, et al.
Publicado: (2018)

Simplified Admix Archaeal Glycolipid Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Enhances Protection from Murine Melanoma
por: Stark, Felicity C., et al.
Publicado: (2019)

Blood-Based Immune Protein Markers of Disease Progression in Murine Models of Acute and Chronic Inflammatory Bowel Disease
por: Renner, Tyler Milston, et al.
Publicado: (2023)

Evaluation of Adjuvant Activity and Bio-Distribution of Archaeosomes Prepared Using Microfluidic Technology
por: Jia, Yimei, et al.
Publicado: (2022)

The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combined with Different Adjuvants in a Murine Model
por: Jia, Yimei, et al.
Publicado: (2021)

Sulfated Lactosyl Archaeol Archaeosomes Synergize with Poly(I:C) to Enhance the Immunogenicity and Efficacy of a Synthetic Long Peptide-Based Vaccine in a Melanoma Tumor Model
por: Akache, Bassel, et al.
Publicado: (2021)

An Archaeosome-Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Significantly Enhances Protection from Murine Melanoma
por: Stark, Felicity C., et al.
Publicado: (2017)

Mechanistic insight into the induction of cellular immune responses by encapsulated and admixed archaeosome-based vaccine formulations
por: Agbayani, Gerard, et al.
Publicado: (2020)

Tuning the immune response: sulfated archaeal glycolipid archaeosomes as an effective vaccine adjuvant for induction of humoral and cell-mediated immunity towards the SARS-CoV-2 Omicron variant of concern
por: Renner, Tyler M., et al.
Publicado: (2023)

Sulfated Lactosyl Archaeol Archaeosome-Adjuvanted Vaccine Formulations Targeting Rabbit Hemorrhagic Disease Virus Are Immunogenic and Efficacious
por: Akache, Bassel, et al.
Publicado: (2023)

Sulfated archaeal glycolipid archaeosomes as a safe and effective vaccine adjuvant for induction of cell-mediated immunity
por: McCluskie, Michael J., et al.
Publicado: (2017)

Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern
por: Akache, Bassel, et al.
Publicado: (2022)

Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters
por: Stark, Felicity C., et al.
Publicado: (2022)

Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant
por: Akache, Bassel, et al.
Publicado: (2021)

Characterization of Systemic and Mucosal Humoral Immune Responses to an Adjuvanted Intranasal SARS-CoV-2 Protein Subunit Vaccine Candidate in Mice
por: Maltseva, Mariam, et al.
Publicado: (2022)

Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine
por: Law, John L. M., et al.
Publicado: (2018)

Anti-IgE Qb-VLP Conjugate Vaccine Self-Adjuvants through Activation of TLR7
por: Akache, Bassel, et al.
Publicado: (2016)

Homologous Prime-Boost Vaccination with OVA Entrapped in Self-Adjuvanting Archaeosomes Induces High Numbers of OVA-Specific CD8(+) T Cells that Protect Against Subcutaneous B16-OVA Melanoma
por: Stark, Felicity C., et al.
Publicado: (2016)

Enhanced Activation of Memory, but Not Naïve, B Cells in Chronic Hepatitis C Virus-Infected Patients with Cryoglobulinemia and Advanced Liver Fibrosis
por: Santer, Deanna M., et al.
Publicado: (2013)

A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
por: Law, John Lok Man, et al.
Publicado: (2013)

Preclinical evaluation of manufacturable SARS-CoV-2 spike virus-like particles produced in Chinese Hamster Ovary cells
por: Alpuche-Lazcano, Sergio P., et al.
Publicado: (2023)

Adjuvanted Schistosoma mansoni-Cathepsin B With Sulfated Lactosyl Archaeol Archaeosomes or AddaVax™ Provides Protection in a Pre-Clinical Schistosomiasis Model
por: Perera, Dilhan J., et al.
Publicado: (2020)

A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
por: Johnson, Janelle, et al.
Publicado: (2019)

Ringbodies in Anæmia
por: Monro, T. K., et al.
Publicado: (1925)

Progress towards a hepatitis C virus vaccine
por: Man John Law, Lok, et al.
Publicado: (2013)

An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity
por: Fluckiger, Anne-Catherine, et al.
Publicado: (2021)

No Evidence for XMRV Nucleic Acids, Infectious Virus or Anti-XMRV Antibodies in Canadian Patients with Chronic Fatigue Syndrome
por: Steffen, Imke, et al.
Publicado: (2011)

CpG ODN and ISCOMATRIX Adjuvant: A Synergistic Adjuvant Combination Inducing Strong T-Cell IFN-γ Responses
por: McCluskie, Michael J., et al.
Publicado: (2013)

Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8(+) T Cell Responses to Chronic Viral Infections and Cancer
por: Okoye, Isobel S., et al.
Publicado: (2017)

SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1
por: Law, John Lok Man, et al.
Publicado: (2021)

Dissociation by steroids of eosinophilic inflammation from airway hyperresponsiveness in murine airways
por: Birrell, Mark A, et al.
Publicado: (2003)

Application of functional genomics to the chimeric mouse model of HCV infection: optimization of microarray protocols and genomics analysis
por: Walters, Kathie-Anne, et al.
Publicado: (2006)

The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development
por: Cashman, Siobhán B., et al.
Publicado: (2014)

To Include or Occlude: Rational Engineering of HCV Vaccines for Humoral Immunity
por: Schlotthauer, Felicia, et al.
Publicado: (2021)

HCV Induces Oxidative and ER Stress, and Sensitizes Infected Cells to Apoptosis in SCID/Alb-uPA Mice
por: Joyce, Michael A., et al.
Publicado: (2009)

A memory of longevity
por: Emerson, Felicity, et al.
Publicado: (2020)

The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections
por: Egli, Adrian, et al.
Publicado: (2014)

Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolism
por: Sarhan, Mohammed A., et al.
Publicado: (2017)

HCV and flaviviruses hijack cellular mechanisms for nuclear STAT2 degradation: Up-regulation of PDLIM2 suppresses the innate immune response
por: Joyce, Michael A., et al.
Publicado: (2019)

Site-directed transposon integration in human cells
por: Yant, Stephen R., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ool3mli6clc4au9a5gn6ldeapl